Add to Calendar
aCLuDhaqizCaPxAftmqF16720408/13/2020 05:00 PM08/19/2020 09:00 PMfalseNational Broadcast to Announce the Approval of a Second Indication for TAZVERIK™ (tazemetostat)
Learn more about a new treatment option for your relapsed or refractory follicular lymphoma (FL) patients
In this Live Broadcast, Dr. Pagel, Dr. Burke, and Dr. Kurtin will:
Review the Prescribing Information for this new treatment available for relapsed or refractory FL patients
Present clinical safety and efficacy data in this patient population
Provide important dosing and patient counseling information
Discuss a hypothetical patient case study
Click here to register
View the flier
WEBINAR - Multiple Broadcast Times